This work is licensed under the Creative Commons Attribution 4.0 International License.
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65.QinJLiRRaesJArumugamMBurgdorfKSManichanhCA human gut microbial gene catalogue established by metagenomic sequencingNature20104645965Search in Google Scholar
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–80.ArumugamMRaesJPelletierELe PaslierDYamadaTMendeDREnterotypes of the human gut microbiomeNature201147317480Search in Google Scholar
Liu W, Cheng M, Li J, Zhang P, Fan H, Hu Q, et al. Classification of the gut microbiota of patients in intensive care units during development of sepsis and septic shock. Genomics, Proteomics Bioinformatics. 2020;18(6):696–707.LiuWChengMLiJZhangPFanHHuQClassification of the gut microbiota of patients in intensive care units during development of sepsis and septic shockGenomics, Proteomics Bioinformatics2020186696707Search in Google Scholar
Amon P, Sanderson I. What is the microbiome? Arch Dis Child Educ Pract Ed. 2017;102(5):257–60.AmonPSandersonIWhat is the microbiome?Arch Dis Child Educ Pract Ed2017102525760Search in Google Scholar
Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppe E. The role of the microbiota in the management of intensive care patients. Ann Intensive Care. 2022;12(1):3.SzychowiakPVillageois-TranKPatrierJTimsitJFRuppeEThe role of the microbiota in the management of intensive care patientsAnn Intensive Care20221213Search in Google Scholar
Wolf AJ, Underhill DM. Peptidoglycan recognition by the innate immune system. Nat Rev Immunol. 2018;18:243–54.WolfAJUnderhillDMPeptidoglycan recognition by the innate immune systemNat Rev Immunol20181824354Search in Google Scholar
Emonet S, Lazarevic V, Leemann Refondini C, Gaia N, Leo S, Girard M, et al. Identification of respiratory microbiota markers in ventilator-associated pneumonia. Intensive Care Med. 2019;45:1082–92.EmonetSLazarevicVLeemann RefondiniCGaiaNLeoSGirardMIdentification of respiratory microbiota markers in ventilator-associated pneumoniaIntensive Care Med201945108292Search in Google Scholar
Wolff NS, Hugenholtz F, Wiersinga WJ. The emerging role of the microbiota in the ICU. Crit Care. 2018;22(1):78.WolffNSHugenholtzFWiersingaWJThe emerging role of the microbiota in the ICUCrit Care201822178Search in Google Scholar
Schlechte J, Zucoloto AZ., Yu IL, Doig CJ, Dunbar MJ, McCoy KD, et al. Dysbiosis of a microbiota–immune metasystem in critical illness is associated with nosocomial infections. Nat Med. 2023;29(4):1017–27.SchlechteJZucolotoAZYuILDoigCJDunbarMJMcCoyKDDysbiosis of a microbiota–immune metasystem in critical illness is associated with nosocomial infectionsNat Med2023294101727Search in Google Scholar
Lankelma JM, van Vught LA, Belzer C, Schultz MJ, van der Poll T, de Vos WM, et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med. 2017;43:59–68.LankelmaJMvan VughtLABelzerCSchultzMJvan der PollTde VosWMCritically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot studyIntensive Care Med2017435968Search in Google Scholar
Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:954–62.SiemposIINtaidouTKFalagasMEImpact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trialsCrit Care Med20103895462Search in Google Scholar
Azamfirei L. Personalized physiological medicine as the future of intensive care medicine. J Crit Care Med. 2022;8(3):143–4.AzamfireiLPersonalized physiological medicine as the future of intensive care medicineJ Crit Care Med2022831434Search in Google Scholar
Lazăr A, Azamfirei L. Personalized medicine for the critically ill patient: a narrative review. Processes. 2022;10(6).LazărAAzamfireiLPersonalized medicine for the critically ill patient: a narrative reviewProcesses2022106Search in Google Scholar
Behrouzi A, Nafari AH, Siadat SD. The significance of microbiome in personalized medicine. Clin Transl Med. 2019;8(1):16.BehrouziANafariAHSiadatSDThe significance of microbiome in personalized medicineClin Transl Med20198116Search in Google Scholar
Georgescu AM, Bănescu C, Badea I, Moldovan V, Hutanu A, Voidazan S, et al. IL-6 gene polymorphisms and sepsis in ICU adult Romanian patients: a prospective study. Rev Romana Med Lab. 2017;25(1):75–89.GeorgescuAMBănescuCBadeaIMoldovanVHutanuAVoidazanSIL-6 gene polymorphisms and sepsis in ICU adult Romanian patients: a prospective studyRev Romana Med Lab20172517589Search in Google Scholar
Lazăr A, Georgescu AM, Vitin A, Azamfirei L. Precision Medicine and its role in the treatment of sepsis: a personalised view. J Crit Care Med. 2019;5:90–6.LazărAGeorgescuAMVitinAAzamfireiLPrecision Medicine and its role in the treatment of sepsis: a personalised viewJ Crit Care Med20195906Search in Google Scholar
Kashyap PC, Chia N, Nelson H, Segal E, Elinav E. Microbiome at the frontier of personalized medicine. Mayo Clin Proc. 2017;92(12):1855–64.KashyapPCChiaNNelsonHSegalEElinavEMicrobiome at the frontier of personalized medicineMayo Clin Proc20179212185564Search in Google Scholar
Di Domenico M, Ballini A, Boccellino M, Scacco S, Lovero R, Charitos IA, et al. The intestinal microbiota may be a potential theranostic tool for personalized medicine. J Pers Med. 2022;12:523.Di DomenicoMBalliniABoccellinoMScaccoSLoveroRCharitosIAThe intestinal microbiota may be a potential theranostic tool for personalized medicineJ Pers Med202212523Search in Google Scholar